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OBJECTIVE: The objective of this selective EBM review is to determine whether or not “a 
modified dialectical behavior therapy (DBT) regimen is effective in reducing PTSD symptom 
severity in adult women with comorbid PTSD and BPD?”  
 
STUDY DESIGN: Review of two randomized controlled trials (RCTs) and one case study 
published in English between 2013-2015.  
 
DATA SOURCES: Two RCTs and one case study found via PubMed and Google Scholar 
evaluated the benefit of a modified dialectical behavior therapy (DBT) in reducing PTSD 
symptom severity in patients with comorbid PTSD and BPD.  
 
OUTCOMES MEASURED: PTSD Symptom severity was measured via the Clinician-
Administered PTSD Scale (CAPS), PTSD Symptom Scale – Interview (PSS-I), and PTSD 
Checklist (PCL).  
 
RESULTS: Both RCT’s performed by Bohus et al. (Psychother Psychosom. 2013;82(4):221223. 
doi: 10.1159/000348451) and Harned et al. (Behav Res Ther. 2014;55:7-17. doi: 10.1016/j.brat.2 
014.01.008) found a statistically significant relationship between a modified DBT regimen, 
DBT-PTSD or DBT + DBT PE respectively, and a marked reduction in PTSD symptom severity 
as compared to the control group. Granato et al. (J. Clin. Psychol. 2015;71:805 -815. doi: 10.100 
2/jclp/22207) conducted a case study that descriptively revealed the patient’s reduced PTSD 
symptomatology after completing DBT + DBT PE yet is deficient in its ability to produce 
significant data due to their lack of sample size.  
 
CONCLUSIONS: The reported evidence in each study supports the efficacy of a modified DBT 
regimen in the marked reduction of PTSD symptom severity in adult women with co-occurring 
PTSD and BPD. However, only the two RCTs by Bohus et al and Harned et al. elicited data with 
statistical significance. Based on the findings from these two trials, it is evident that women who 
severely suffer from both mental illnesses are capable of reducing their PTSD symptomatology 
with potential remission from one of the diagnoses after completion of a modified DBT 
treatment, as compared to traditional DBT that is unable to elicit the same change. These studies 
prove that it is imperative to simultaneously target both symptomatic manifestations of BPD and 
PTSD that co-occur and cause significant impairment. Future research should focus on 
expanding sample sizes and lengthening follow-up measures to assess the treatment’s long-term 
impact on psychological remission.   
 
KEY WORDS: Borderline Personality Disorder, Post-Traumatic Stress Disorder, Dialectical 
Behavior Therapy, Psychotherapy.  
 
 





 Borderline personality disorder (BPD) frequently surfaces from late adolescence to early 
adulthood and is characterized by marked impulsivity in areas of spending, substance abuse, or 
sexual acts, drastic fluctuations in mood and temper, unstable interpersonal relationships, self-
injurious behavior and distortions of self-image. The pattern of this disorder is impairing, as it is 
known to harshly impact close relationships. Those affected by this disorder are unable to 
reconcile with other people’s opposing opinions, also referred to as “splitting,” causing the 
individual to dramatically go from a state of idealization to devaluation in the smallest conflict.1  
First-line treatment for BPD is psychotherapy, such as dialectical behavior therapy 
(DBT), mentalization-based therapy, transference-focused treatment, and cognitive behavioral 
therapy.1 DBT is the best empirically supported treatment for BPD and is a comprehensive 
treatment program involving individual therapy sessions, group therapy, and therapist teams 
prioritizing patients with emotional dysregulation, intentional self-injury, and suicidal 
tendencies. Its change-oriented approach originates in the concepts of mindfulness and instilling 
awareness about how destructive emotionally driven reactions are in their lives, which then shifts 
into a new motivation to create personal change. This realization allows patients to render a new 
balance between acceptance and validation of their harmful tendencies. The therapist avoids 
portraying concepts as “right” or “wrong,” yet molds their opinion with that of the patient. 
Together, they develop strategies to restructure and remove triggers in the patient’s daily 
environment, imparting new behavioral techniques that will mitigate negative responses caused 
by internal distress and prioritizes preserving negatively affected interpersonal relationships.2 
Pharmacotherapy is understudied, yet antipsychotics like olanzapine, antidepressants like 
fluoxetine, or mood stabilizers like lamotrigine, may reduce targeted symptoms.1   
Kearney, Modified DBT Reduce PTSD Symptoms       
 
2 
 Post-traumatic stress disorder (PTSD) arises in individuals after they endure an impactful 
traumatic event, which may include sexual/physical assault, childhood trauma, experiencing a 
natural disaster or medical catastrophe, or being a prisoner at war. Symptomatic manifestations 
are divided into 4 categories: intrusion symptoms or re-experiencing the trauma via flashbacks or 
thoughts, avoiding trauma-related stimuli, alterations in cognition and mood, and heightened 
levels of arousal. Treatment measures fall in the realm of psychotherapies, as CBT with exposure 
therapy are proven efficacious. If patients are unresponsive to the above, SSRIs like sertraline, 
SNRIs like venlafaxine, or anti-psychotics like risperidone, are used along with psychotherapy.3   
 The onset of PTSD not only doubles the frequency of intentional self-injury in 
individuals with BPD, but those with both PTSD and BPD are a particularly high-risk group with 
a 2-5 times increased risk of completing suicide compared to someone with either BPD or 
PTSD.4 While CBT has been successful in the treatment of PTSD alone, CBT explicitly excludes 
individuals who self-harm or who are acutely suicidal, essentially eliminating PTSD patients 
with comorbid BPD. Traditional CBT therefore fails to treat co-occurring PTSD and BPD. This 
comorbidity is gaining clinical significance, as the dual presence maintains and intensifies the 
affected individual’s emotional dysregulation, non-suicidal self-injury (NSSI), and dampens 
overall remission rates.4 DBT is indicated in BPD patients, but prioritizes self-injury and other 
behavior dysfunctions, without specifically targeting a patient’s underlying PTSD diagnosis.5 
 The lifetime prevalence of PTSD alone is twice as high in women compared to men (10-
12% vs. 5-6%, respectively). About 30% of people with PTSD have a dual diagnosis of BPD.4,6,7 
While there’s limited data on the specific distribution of women with comorbid illnesses, these 
statistics suggest a disproportionate effect on females. The cost of a modified DBT protocol has 
not yet been standardized in the U.S. The mean total cost of traditional DBT in the U.K. was 
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higher than treatment as usual (£5,685 vs. £3,754)6 but after comparing expenditures on health 
services pre- and post-treatment, patients saved £36,000 after the post-treatment year.8 
 Data that account for the yearly visits amongst women with comorbid PTSD and BPD 
has not yet been quantified. Additional data separating the number of BPD and PTSD medical 
visits is inadequate and falsely low, as providers, especially at the primary care level, often come 
up short in their clinical capacity to diagnose these mental disorders.9 Physician assistants (PAs) 
are a vital component within primary care, clinically educated in behavioral medicine. Since PAs 
and patients form enduring relationships, recognition of new behavioral changes from their 
baseline should prompt referral to mental health services even without certainty of a diagnosis.  
 Currently, there is no universally accepted standardized treatment model for patients with 
co-occurring PTSD and BPD. Clinical trials have assessed new forms of DBT that uniquely 
target patients with these diagnoses. The two variants of DBT are named DBT-Prolonged 
Exposure (DBT + DBT PE) and DBT-PTSD.4,5,10 DBT-PTSD is a comprehensive modular 
program that includes a psychoeducation program and trauma-focused interventions that pinpoint 
high-risk traits, such as dissociation and self-harm, and imparts new skills via mindfulness 
training and exposure-based individual interventions to control their actions associated with 
heightened emotional dysregulation.5 DBT + DBT PE starts with 1 year of traditional DBT, and 
if/when participants achieve control over their high-priority symptoms, such as suicidal 
tendencies or severe quality of life-interfering behaviors, the PE portion begins. Patients are 
directly exposed to traumatic memories and learn processing techniques to combat the onset of 
global distress.4,10 Standard DBT is not indicated in patients with PTSD, yet because of its co-
occurrence with BPD that in turn exacerbates self-harming tendencies, a modified DBT that 
specifically targets debilitating behaviors has elicited groundbreaking clinical improvement. 




The objective of this selective EBM review is to determine whether or not “a modified 
dialectical behavior therapy (DBT) regimen is effective in reducing PTSD symptom severity in 
adult women with comorbid PTSD and BPD?”  
METHODS  
The search was conducted within PubMed and ClinicalKey using specific inclusion 
criteria for this review, in which 2 unblinded RCTs and 1 case study were chosen. The patient 
population is composed of adult women, 18 years and older, with PTSD and BPD. The 
interventions are modified dialectical behavior therapies (DBT + DBT PE and DBT-PTSD). The 
control group used for comparison underwent the treatment-as-usual wait list (TAU-WL) 
protocol or traditional DBT. The outcome measured is reduction in PTSD symptom severity.  
DATA SOURCES: 
Keywords that were used when searching for articles were “BPD,” “PTSD,” “DBT” and 
“psychotherapy.” Each article is published in a peer review journal and written in the English 
language. Articles were selected based on their relevance to the clinical question and their 
inclusion of patient oriented outcomes (POEMS). The inclusion criteria for articles used in this 
review were as follows: studies published after 2011, RCT, modified DBT, subjects with 
comorbid PTSD and BPD, and adult women 18 years and older. Exclusion criteria for articles 
included studies published before 2011, studies with men or children under age 18, standard 
DBT, and studies focusing on patients with BPD or PTSD alone. Summary of statistics reported 
include p-value, numbers needed to treat (NNT), experimental event rate (EER), control event 
rate (CER), relative benefit increase (RBI), and absolute benefit increase (ABI).  
OUTCOMES MEASURED 
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 The outcomes measured in these articles were all POEMs. Harned et al.4 measured the 
efficacy of DBT + DBT PE in reducing PTSD symptomology via the PTSD Symptom Scale-
Interview (PSS-I), with content corresponding to DSM-IV PTSD diagnostic criteria. PTSD 
remission was defined as no longer meeting DSM-IV diagnostic criteria, and PTSD symptomatic 
severity reduction was assessed by comparing changes in participant’s scores on the PSS-I 
throughout the intervention, with a maximum score of 51 points. Bohus et al.5 measured the 
efficacy of DBT-PTSD in reducing PTSD symptom severity via a Clinician-Administered PTSD 
Scale (CAPS) score, with “treatment response” defined as a reduction of 30 out of the 60-point 
score. Patients who gained “full remission” from their original PTSD diagnosis no longer met the 
DSM-IV criteria after completion of the trial. Granato et al.10 measured the efficacy of DBT + 
DBT PE in reducing PTSD symptomatology via the 17-item PTSD checklist (PCL) that 
corresponds to the DSM-IV PTSD criteria. The participant answered each question on a 5-point 
Likert scale: 1 defined as “not at all” to 5 defined as “extremely,” in terms of how significantly 
their symptoms impacted them in the past week. The highest possible score totals to 85 points, 
with a score < 45 considered to be out of the diagnostic range for PTSD.  
Table 1: Demographics & Characteristics of Reviewed Articles  







IV PTSD related to 
childhood sexual abuse; 
patients met 1 of the 
following: current 
eating disorder, MDD, 
substance abuse, >4 
DSM-IV for BPD   
Men or children; 
lifetime diagnosis of 
schizophrenia, current 
substance dependence, 
BMI < 16.5, intellectual 
disability, medical 
conditions contradicting 
the exposure protocol 
(CVD etc.) and suicidal 
behavior in the past 4 
months.    








Females who meet 
DSM-IV criteria for 
both BPD and PTSD; 
can remember at least 
some part of index 
trauma; recent/recurrent 
Met DSM-IV criteria 
for a psychotic disorder, 
bipolar disorder, or 
mental retardation; 
legally mandated to 
treatment; if patient 
8 1 year of standard DBT 
coupled with a modified 
DBT + DBT PE protocol 
that starts once 
improvement in select 




participant lives within 
close proximity to the 
clinic 
required a primary 








1 31  Adult female who 
meets DSM-IV criteria 
for both PTSD and 
BPD; significant 
trauma history 
None reported  0 10-month period – 
begins as standard DBT 
requiring 14 sessions and 
then integrates DBT + 
DBT PE that is delivered 
in 27 sessions.  
 
RESULTS  
 Bohus et al.5 conducted an RCT where 82 adult women were randomized in a 1:1 
allocation ratio. Participants in the experimental group completed a DBT-PTSD program versus 
the control group where participants completed treatment-as-usual wait list (TAU-WL), 
undergoing 6 months of a treatment of their choice excluding DBT-PTSD.5 All patients had a 
DSM-IV defined diagnosis of PTSD related to childhood sexual abuse and > 4 DSM-IV defined 
diagnosis of BPD. In the first 3 days after randomization, 8 candidates became ineligible to 
participate, leaving 74 participants included in the analysis.5 A total of 69 participants completed 
the whole trial after 5 participants dropped out during the trial, with no significant dropout rate 
associated with either intervention. Participants were further broken down for data analysis into 2 
groups based on the severity of their BPD diagnosis according to DSM-IV criteria, with 33 
participants who fit into the > 5 BPD criteria (DBT-PTSD, n = 17; TAU-WL, n = 16) versus 41 
participants who fit into the < 5 BPD criteria (DBT-PTSD, n = 19; TAU-WL, n = 22).5  
 Data were collected at admission into the study, at 12 weeks, 18 weeks, and 24 weeks; 
post-discharge follow-up at 6 and 12 weeks was garnered from the DBT-PTSD group.5 The 
mean change in the CAPS score was greater in the DBT-PTSD group, with a mean reduction of 
33.16 points, while those in the TAU-WL group only saw a mean reduction of 2.08 points.5  
Both subgroups in the DBT-PTSD arm, meeting > 5 BPD or < 5 BPD, showed significant 
weekly improvement on the CAPS scores compared to the control groups (-1.510 + 0.249, p < 
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0.001 and -0.496 + 0.234, p = 0.038, respectively).5 More participants on the DBT-PTSD arm 
showed a significant response to treatment, with 29.4% (n=5) in DBT-PTSD and 0.0% for TAU-
WL, with a p-value of 0.039.5 NNT, CER, EER, RBI, and ABI are reported in table 2.  
Table 2. Treatment Responders Using CAPS Scores5 
CER EER RBI ABI NNT 
0.0 0.294 0.0 0.294 4 
 
Harned et al.4 conducted an RCT in an outpatient setting where 26 participants were 
randomized to 2 groups. Participants were allocated in a 2:1 ratio to the experimental group, 1 
year of DBT with prolonged exposure (DBT + DBT PE) protocol, versus the control group in 
which participants completed 1 year of standard DBT. The experimental group had double the 
amount to maximize the amount receiving the intervention under investigation, with n = 17 in the 
DBT + DBT PE and n = 9 in DBT alone.4 All participants were adult women who reported 
intentional self-injury, had experienced some past traumatic life event, with dual diagnoses of 
BPD and PTSD.4 Participants in the control group reported intense urges to commit suicide pre- 
and post-treatment as compared to the experimental group, in which 2 people relapsed in 
intentional bodily injury and 1 successfully completed suicide during the study.4 In the 
experimental group, 1 person made a suicide attempt, and 1 reported self-injury.4   
 Subjects were assessed pre-treatment, at 4-month intervals within the period of 
treatment, and at 3-months follow-up, with a specific focus on the content garnered from 
participants after completion of the PSS-I during these time periods.4 There was an attrition of 
31%; the dropout rate did not significantly associate to either treatment group. Ten participants 
completed the experimental trial after 7 dropped out, and 5 participants completed the control 
trial, after 4 dropped out.4  
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In the experimental group, 58.3% of participants were in PTSD remission at post-
treatment versus 33.3% in the control group.4 Completers in the experimental group were 1.3 
times more likely to report clinically significant PTSD symptom reduction and 2 times more 
likely to achieve diagnostic remission from PTSD.4 At 3-month follow-up, 50% of the 
experimental group remained in PTSD remission, compared to 0% of the control group.4 An 
MMANOVA assessing “time x condition x completer” amongst participants who completed the 
DBT + DBT PE protocol and with assessing PTSD symptomatology, rendered an F-value = 
3.43,42 with a p-value < 0.05.4 This confirmed that the experimental group had the largest PTSD 
symptom reduction out of the two treatment groups.4   
Table 3: Treatment Responders Using PSS-I Scores4 
CER EER RBI ABI NNT 
0.667 0.833 0.25 0.166 6 
 
 Granato et al.10 conducted a case study on an adult female with DSM-IV diagnosed 
PTSD and BPD, who experienced traumatic childhood events with tendencies to experience 
dissociative symptoms that cause her to self-harm.10 The traumatic event of greatest impact 
occurred at the age of 12 when she was unknowingly drugged, subsequently gang-raped and 
beaten.10 The course of treatment includes a 41-session regimen persisting over a 10-month 
period, with standard DBT delivered in the first 14 sessions, wherein the DBT + DBT PE 
protocol is introduced and delivered in the remaining 27 sessions.10 Prolonged exposure occurred 
in three phases - preexposure, exposure, and termination and consolidation, and was effective in 
making the participant confront the memory of past trauma and change fear-based cognitions and 
responses to these emotions. PE was discontinued if the patient was actively self-harming.10  
 The participant completed the 41-session treatment protocol in full.10 Midway through 
treatment between sessions 19-20, the patient participated in hallucinogenic drug use and 
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intentional self-harm, in which PE was halted for a total of 5 sessions and then resumed. The 
patient self-harmed again at session 28 without serious injury, in which PE was halted and 
resumed the next session. No other threats to her safety were reported.10 The table below elicits 
the participant’s PCL score reduction of 25 points over time, totaling at 55. This score was 
determined to be in the diagnostic range for active PTSD according to current guidelines.10  
Table 4. PTSD Checklist (PCL) Scores During PE Treatment10  
 Session 15 (pre-exposure PE) Session 41 (last PE session) 
PCL Score 80 55 
Total point reduction 25 points 
 
DISCUSSION  
 Bohus et al.5 deemed their DBT-PTSD treatment method to have a statistically significant 
impact in reducing PTSD symptom severity in the experimental group, also defined as 
participants “responding to treatment,” endorsed by a p-value of 0.039. PTSD remission rates 
amongst patients meeting diagnostic criteria for BPD was 41.2% vs. 0.0% in the control group, 
with p = 0.0058. Harned et al.4 found that both DBT and DBT + DBT PE endeavors were 
effective in reducing PTSD symptom severity in participants, as the experimental group achieved 
greater reduction in symptoms (80% vs. 60%) and remission rates post-treatment (80% vs. 40%) 
as compared to DBT alone, respectively. Individuals with a severe co-occurrence of these 
illnesses often self-harm, and traditional PTSD treatment protocols persistently exclude these 
persons from receiving care. Yet, those in the experimental group reported a reduced desire to 
self-injure, which impacted their perception of the treatment protocol and eventual decline in 
PTSD symptoms.4 Both RCTs had an NNT of 4 and 6, translating as a large treatment effect.4,5  
Granato et al.10 carried out a case study conducted on one adult female, and researchers 
considered their results to be “clinically” significant yet not generalizable to a larger patient 
population. The researchers believed that the patient’s dramatic decrease of 25 points on the 
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PTSD checklist (PCL) elicits significance in the DBT + DBT PE regimen while also assessing 
her clinical picture subsequent, in which her dissociative and self-harming tendencies were 
greatly reduced in conjunction with her PTSD symptoms.10 
 One stark flaw that stands out for all the studies is the lack of a substantial sample size, in 
which attrition rates are high in both RCTs. Harned et al.4 had an observed attrition of 31%, and 
Bohus et al.5 had an attrition totaling to 16% and neither study carried out worst-case analyses to 
account for these losses. There were a multitude of reasons that participants dropped out, as the 
impulsive nature of their severe mental illness, lack of global functioning, and self-injurious 
behavior most certainly impacted attrition rates. All studies had less than 100 participants, but 
the small initial sample size can be explained in part by how individualistic, unique and time-
consuming each treatment plan is, as participants were strategically paired with specially trained 
clinicians recruited to function in these studies. Also, the RCTs control groups lack homogeneity 
with each other, as Harned et al.4 participants completed standard DBT, yet Bohus et al.5 
participants completed a TAU-WL, or their treatment of choice. There is considerable fault in 
allowing patients to choose their own treatment in a trial of this nature, as the group may be 
confounded by unknown factors that researchers are unable to control.   
There were two modified DBT regimens carried out in the three studies, “DBT + DBT 
PE” and “DBT-PTSD,” both of which have similar diagnostic and therapeutic aims yet are not 
fundamentally identical. Although each target a population of patients with the same diagnoses, 
it has been subsequently determined that DBT-PTSD is effective in patients with PTSD and 
moderate BPD without life-threatening behavior, as compared to DBT + DBT PE in its efficacy 
to target patients with PTSD and severe BPD with self-injurious behavior.11 Knowledge of this 
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core disparity amid the two is of importance for researchers when recruiting new subjects and for 
future clinicians advocating for standardization and implementation of these treatment measures.  
CONCLUSION 
 It’s of evolving scientific consensus that adult women with the complex diagnoses of 
PTSD and BPD suffer through an unrelenting course of illness that has proven to be resistant to 
the standard, universally recognized treatments. As previously reviewed, the dual diagnosis of 
PTSD and BPD is clearly ubiquitous, as individuals have a higher incidence to intentionally self-
injure and a lower likelihood to benefit from treatment measures that independently target PTSD 
or BPD alone. PTSD can actually inhibit someone from achieving full diagnostic remission from 
BPD, which illustrates the clinical significance in focusing on reducing PTSD symptoms as a 
core feature of these novel DBT treatments to be replicated in future research endeavors. The 
modified DBT regimens analyzed in this review, DBT-PTSD and DBT + DBT PE, have proven 
a robust statistically significant impact in their ability to bate PTSD symptomatology and allow 
subjects to achieve full diagnostic remission from both illnesses, thus rendering them as 
promising treatment options in adult women with co-occurring PTSD and BPD.  
 Future research should prioritize recruitment of a larger, more robust sample with a plan 
to combat the high dropout rates. There is great significance in longer-term follow-up measures 
especially in an area of this focus, as knowledge of a subject’s lasting psychological remission 
and enhanced quality of life thereafter should be of great importance. Further trials should revise 
and refine these DBT measures, with an aim to personally standardize and individually tailor a 
treatment option to patients with both BPD and PTSD who fall on a spectrum of disease severity. 
 
   
REFERENCES 
 
1. Borderline personality disorder: clinical overview. ClinicalKey. https://www.clinicalke 
y.com/#!/content/clinical_overview/67-s2.0-ae4d29c6-3bc5-4294-9f16-434d6932bfe9?s 
crollTo=%23references. Published September 18, 2019. Accessed October 1, 2019.  
 
2. Stoffers-Winterling JM, Vollm BA, Rucker G, Timmer A, Huband N, Lieb K. 
Psychological therapies for people with borderline personality disorder. Cochrane 
Database of Systematic Reviews. 2012;8. doi: 10.1002/14651858.CD005652.pub2. 
 
3. Postttraumatic stress disorder: Clinical Overview. ClinicalKey. https://www.clinicalkey 
.com/#!/content/clinicaloverview/67-s2.0-0361f0fa-0f5b-4d7b-af8d-62cc79ee76c0. 
Published August 27, 2019. Accessed October 1, 2019.  
 
4. Harned MS, Korslund KE, Linehan MM, et al. A pilot randomized controlled trial of 
dialecti cal behavior therapy with and without dialectical behavior therapy prolonged 
exposure protocol for suicidal and self-injuring women with borderline personality 
disorder and PTSD. Behav Res Ther. 2014;55:7-17. doi: 10.1016/j.brat.2014.01.008.   
 
5. Bohus M, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic 
stress disorder after childhood sexual abuse in patients with and without borderline 
personality disorder: a randomised controlled trial. Psychother Psychosom. 
2013;82(4):221-223. doi: 10.1159/000348451.  
 
6. Olff M. Sex and gender differences in post-traumatic stress disorder: an update. Eur J 
Psychotraumatol. 2017;8(sup4):1351204. Published 2017 Sep 29. doi:10.1080/2 
0008198.2017.1351204. 
 
7. Pagura J, Stein MB, Bolton JM, Cox BJ, Grant B, Sareen J. Comorbidity of borderline 
personality disorder and posttraumatic stress disorder in the U.S. population. J Psychiatr 
Res. 2010 Dec;44(16):1190-8. doi: 10.1016/j.jpsychires.2010.04.016. 
 
8. Amner K. The effect of DBT provision in reducing the cost of adults displaying the 
symptoms of BPD. Br. J. Psychother. 2012;28(3):336-52.  
 
9. Greene T, Neria Y, Gross R. Prevalence, Detection and correlates of PTSD in the 
primary care setting: a systematic review. J Clin Psychol Med Settings. 2016;23(2):160-
180. doi: 10.1007/s10880-01609449-8.  
 
10. Granato H, Wilks C, Miga E, Korslund K, Linehan M. The use of dialectical behavior 
therapy and prolonged exposure to treat comorbid dissociation and self-harm: the case of 
a client with borderline personality disorder and posttraumatic stress disorder. J. Clin. 
Psychol. 2015;71:805-815. doi: 10.1002/jclp/22207.  
 
   
11. Harned, MS. The combined treatment of PTSD with borderline personality disorder. 
Curr Treat Options Psychiatry. 2014;1(4):335-344. Doi.org/10.1007/s40501-014-0025-
2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
